Efficiency of CO2 -baited CDC miniature light traps under semi-field conditions and characterizing response behaviors of female Aedes aegypti (Diptera: Culicidae).

Aedes aegypti (L.) (Diptera: Culicidae) is an important vector of viruses causing dengue, Zika, chikungunya, and yellow fever and as such is a threat to public health worldwide. Effective trapping methods are essential for surveillance of both mosquito species and disease presence. The Centers for Disease Control Miniature Light Trap (CDC-MLT) is an updated version of the New Jersey light trap, which was developed early in the 20th century. This trap is widely reported as being less successful for Ae. aegypti than for other mosquito species, although the reason for this is unclear. This trap has engendered more Ae. aegypti-tailored designs that still represent the basic design model. The efficiency of the CDC-MLT alone and with CO2 was tested under semi-field conditions and the behavior of responding female Ae. aegypti was characterized. The CDC-MLT alone failed to capture any mosquitoes and with CO2 the capture efficiency was less than 2%. Understanding the behaviors that mosquitoes exhibit while encountering a particular trap design or trapping concept may suggest trap improvements to increase capture efficiency. Moreover, this work contributes to our understanding of mosquito host-seeking behavior.

Disposition of flunisolide in the rat, mouse, dog, rhesus monkey, and cynomolgus monkey.

Flunisolide (6 alpha-fluoro-11 beta, 16 alpha, 17 alpha, 21-tetrahydroxypregna-1,4-diene-3,20-dione 16,17-acetonide) administered as a single iv or oral dose to rats, mice, dogs, rhesus monkeys, and cynomolgus monkeys had a plasma t 1/2 of 1-3.5 hr and was eliminated mainly via the bile. After iv administration of 14C-labeled flunisolide, radioactivity was widely distributed into tissues and organs. The apparent volume of distribution of flunisolide in these five species was 3.0-8.0 liters/kg. A major metabolite isolated from rhesus monkey urine was shown to be 6 beta, 11 beta, 16 alpha, 17 alpha, 21-pentahydroxypregna-1,4-diene-3,20-dione 16,17-acetonide (6 beta-OH metabolite). Free 6 beta-OH metabolite was a major radioactive entity detected in urine of all species given radiolabeled flunisolide, whereas flunisolide conjugated with glucuronic acid and/or sulfate was a major metabolite detected in the bile of rats, dogs, and cynomolgus monkeys. Following the oral administration of radiolabeled flunisolide, radioactivity was rapidly and efficiently absorbed in all species, but in the rhesus and cynomolgus monkeys most of the plasma radioactivity was due to the 6 beta-OH metabolite and to water-soluble conjugates, suggesting extensive first-pass metabolism of flunisolide.